{
  "id": "adv_mhgap#risk_safety_e055627d",
  "content": "becomes much smaller after six months. six months post-remission between antidepressants\ny The relapse rate at one year was lower for and pill placebo.\npharmacotherapy compared with placebo. The\n59\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nRemarks Implementation considerations\ny The term “depression” refers to moderate-to-severe y Long-term antidepressant use may be associated\ndepressive episode or disorder. with additional adverse effects such as weight gain.\ny The term “remission” is defined as relief from y Specific types of antidepressants selected should\ndepressive symptoms. carefully consider factors such as demographic\ny The studies identified in the review included characteristics (e.g. higher risks that may be\npeople experiencing first or recurrent episodes associated with pregnancy or older age) and\nof depression. side-effects profiles (e.g. sexual dysfunction, sleep\ny Antidepressants are typically most effective in the problems, weight gain).\ninitial 6–12 months and should only be continued y When discontinuing antidepressants, abrupt\nwhere there is need and clinical oversight. discontinuation should be avoided and medicine\ndoses should be tapered off slowly. Any withdrawal\nResearch gaps symptoms should be closely monitored.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "sleep",
      "risk_safety",
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Risk Safety becomes much smaller after six months. six months post-remission between antidepressants\ny The relapse rate at one year was lower for and pill placebo.\npharmacotherapy compared with placebo. The\n59\nMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders\nRemarks Implementation considerations\ny The term “depression” refers to moderate-to-severe y Long-term antidepressant use may be associated\ndepressive episode or disorder. with additional adverse effects such as weight gain.\ny The term “remission” is defined as relief from y Specific types of antidepressants selected should\ndepressive symptoms. carefully consider factors such as demographic\ny The studies identified in the review included characteristics (e.g. higher risks that may be\npeople experiencing first or recurrent episodes associated with pregnancy or older age) and\nof depression. side-effects profiles (e.g. sexual dysfunction, sleep\ny Antidepressants are typically most effective in the problems, weight gain).\ninitial 6–12 months and should only be continued y When discontinuing antidepressants, abrupt\nwhere there is need and clinical oversight. discontinuation should be avoided and medicine\ndoses should be tapered off slowly. Any withdrawal\nResearch gaps symptoms should be closely monitored. Becomes much smaller after six months. six months post-remission between antidepressants\ny the relapse rate at one year was lower for and pill placebo."
}